Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs2175546 | chr2:107233212 | A/G | 0.000239 | 176 | 26.57 | 23.53 | 25.87 | KM Plot |
PCPG | rs2176029 | chr3:80599924 | A/C | 0.000162 | 178 | 19.53 | 24.03 | 27.4 | KM Plot |
PCPG | rs2181787 | chr13:37534781 | G/C | 0.00031 | 177 | 4.17 | 24.23 | 25.87 | KM Plot |
PCPG | rs2186157 | chr13:37572948 | A/G | 0.000337 | 174 | 4.17 | 24.47 | 25.87 | KM Plot |
PCPG | rs2190806 | chr16:89841055 | A/G | 0.000181 | 176 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs2190808 | chr16:89840856 | C/T | 0.000181 | 176 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs2206816 | chr20:5984414 | G/T | 0 | 175 | 25.53 | 25.7 | 2.93 | KM Plot |
PCPG | rs2208023 | chr22:50249983 | A/G | 0.000156 | 178 | 25.47 | 20.17 | 15.18 | KM Plot |
PCPG | rs2209380 | chr13:48419323 | T/G | 5.83E-5 | 177 | 2.93 | 27.23 | 25.2 | KM Plot |
PCPG | rs2211618 | chr13:37645955 | A/C | 0.00034 | 176 | 4.17 | 22.22 | 25.97 | KM Plot |
PCPG | rs2224379 | chr6:26507434 | A/G | 6.12E-7 | 178 | 10.68 | 32.6 | 24.53 | KM Plot |
PCPG | rs2228479 | chr16:89985940 | G/A | 0.000183 | 174 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs2235488 | chr16:1731306 | G/T | 6.07E-5 | 174 | 25.47 | 18.75 | 19.83 | KM Plot |
PCPG | rs2238527 | chr16:89840708 | C/A | 0.000181 | 176 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs2238530 | chr16:89856001 | C/T | 0.000159 | 177 | 25.87 | 20.37 | 36.37 | KM Plot |